Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Long-term consequences of kidney donation.

Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H, Gross CR, Matas AJ.

N Engl J Med. 2009 Jan 29;360(5):459-69. doi: 10.1056/NEJMoa0804883.

2.

Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.

Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM, Knoll G, Karpinski M, Parikh CR, Gill J, Storsley L, Vlasschaert M, Mamdani M; Donor Nephrectomy Outcomes Research (DONOR) Network..

Transplantation. 2008 Aug 15;86(3):399-406. doi: 10.1097/TP.0b013e31817ba9e3.

PMID:
18698242
3.

Living kidney donors requiring transplantation: focus on African Americans.

Gibney EM, King AL, Maluf DG, Garg AX, Parikh CR.

Transplantation. 2007 Sep 15;84(5):647-9.

PMID:
17876279
4.

Meta-analysis: risk for hypertension in living kidney donors.

Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network..

Ann Intern Med. 2006 Aug 1;145(3):185-96. Review.

PMID:
16880460
5.

The performance of three serum creatinine-based formulas in estimating GFR in former kidney donors.

Ibrahim HN, Rogers T, Tello A, Matas A.

Am J Transplant. 2006 Jun;6(6):1479-85.

6.

Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center.

Gossmann J, Wilhelm A, Kachel HG, Jordan J, Sann U, Geiger H, Kramer W, Scheuermann EH.

Am J Transplant. 2005 Oct;5(10):2417-24.

7.

Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.

Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG.

Ann Intern Med. 2004 Dec 21;141(12):929-37.

PMID:
15611490
8.

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.; National High Blood Pressure Education Program Coordinating Committee..

JAMA. 2003 May 21;289(19):2560-72. Epub 2003 May 14. Erratum in: JAMA. 2003 Jul 9;290(2):197.

PMID:
12748199
9.

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J, Brancati FL.

J Am Soc Nephrol. 2002 Sep;13(9):2363-70.

10.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

National Kidney Foundation..

Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. No abstract available.

PMID:
11904577
11.

Renal outcome 25 years after donor nephrectomy.

Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC.

J Urol. 2001 Dec;166(6):2043-7.

PMID:
11696703
12.

Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O'Connor D, Ojo A, Phillips R, Sika M, Wright J Jr; African-American Study of Hypertension and Kidney Disease..

Am J Kidney Dis. 2001 Oct;38(4):744-53. Erratum in: Am J Kidney Dis 2002 Feb;39(2):444.

PMID:
11576877
13.

No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow-up.

Fehrman-Ekholm I, Dunér F, Brink B, Tydén G, Elinder CG.

Transplantation. 2001 Aug 15;72(3):444-9.

PMID:
11502974
14.

Race and hypertension: science and nescience.

Cooper RS, Kaufman JS.

Hypertension. 1998 Nov;32(5):813-6. No abstract available.

15.

Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.

Bergman S, Key BO, Kirk KA, Warnock DG, Rostant SG.

Am J Kidney Dis. 1996 Mar;27(3):341-6.

PMID:
8604702
16.

Forty-five year follow-up after uninephrectomy.

Narkun-Burgess DM, Nolan CR, Norman JE, Page WF, Miller PL, Meyer TW.

Kidney Int. 1993 May;43(5):1110-5.

17.

Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D.

Hypertension. 1995 Mar;25(3):305-13.

18.

Long-term effects of reduced renal mass in humans.

Kasiske BL, Ma JZ, Louis TA, Swan SK.

Kidney Int. 1995 Sep;48(3):814-9.

19.

Are black living-related renal donors at greater long-term risk of renal complications than white donors?

Laskow DA, Jones P, Deierhoi MH, Dubovsky EV, Julian BA, Barber WH, Diethelm AG, Curtis JJ.

Transplant Proc. 1991 Feb;23(1 Pt 2):1328-9. No abstract available.

PMID:
1989228
20.

Changing patterns of end-stage renal disease due to hypertension.

Qualheim RE, Rostand SG, Kirk KA, Rutsky EA, Luke RG.

Am J Kidney Dis. 1991 Sep;18(3):336-43.

PMID:
1882825

Supplemental Content

Support Center